ORAGENICS INC
For the period ended Dec 31, 2025. Filed Mar 16, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 16, 2026
OGEN$0.35+1.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ (DEFICIT) EQUITY
| Common Stock · Preferred Stock · Additional Paid in · Accumulated · Total Stockholders’ | |||||||
|---|---|---|---|---|---|---|---|
| Shares | Amount | Shares | Amount | Capital | Deficit | (Deficit) Equity | |
| Balances at December 31, 2023 | 102,690 | $103 | 16,955,197 | $1,592,723 | $207,793,582 | $(206,218,254) | $3,168,154 |
| Compensation expense relating to option issuances | — | — | — | — | 516,049 | — | 516,049 |
| Sale of common stock | 185,946 | 186 | — | — | 6,669,674 | — | 6,669,860 |
| Conversion of Series A and B preferred stock to common stock | 750 | — | (9,467,000) | (1,592,723) | 1,592,723 | — | — |
| Conversion of prefunded warrants to common stock | 129,617 | 130 | — | — | 1,840 | — | 1,970 |
| Net loss | — | — | — | — | — | (10,567,918) | (10,567,918) |
| Balances at December 31, 2024 | 419,003 | $419 | 7,488,197 | $— | $216,573,868 | $(216,786,172) | $(211,885) |
| Reverse split fractional shares issued | 107,085 | 107 | — | — | (107) | — | — |
| Compensation expense relating to options | — | — | — | — | 642,364 | — | 642,364 |
| Compensation expense recapture relating to options | — | — | — | — | (86,617) | — | (86,617) |
| Common stock issued for services | 103,306 | 103 | — | — | 124,897 | — | 125,000 |
| Sale of common stock | 258,849 | 259 | — | — | 2,633,931 | — | 2,634,190 |
| Sale of Series H preferred stock | — | — | 660,000 | — | 15,019,700 | — | 15,019,700 |
| Conversion of Series H Preferred Shares into Common Stock | 3,345,296 | 3,345 | (230,709) | — | (3,345) | — | — |
| Conversion of prefunded warrants to common stock | 37,990 | 38 | — | — | 1,102 | — | 1,140 |
| Issuance of Series G Preferred Stock | — | — | 1,000,000 | — | — | — | — |
| Cancellation of Series G Preferred Stock | — | — | (1,000,000) | — | — | — | — |
| Net loss | — | — | — | — | — | (9,842,487) | (9,842,487) |
| Balances at December 31, 2025 | 4,271,529 | $4,271 | 7,917,488 | $— | $234,905,793 | $(226,628,659) | $8,281,405 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.